Lizza E. Hendriks
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
AI-HOPE lung cancer: a multicenter real-world registry integrating artificial intelligence for metastatic non-small-cell lung cancer.
Journal: ESMO real world data and digital oncology
Published: August 14, 2026
KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians.
Journal: Cancer treatment reviews
Published: March 21, 2026
Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC survey.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 14, 2026
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 19, 2026
Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatment.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 16, 2025
Effect of treatment sequencing on outcome of patients with non-small cell lung cancer with a synchronous solitary extrathoracic metastasis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 21, 2025
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer.
Journal: ESMO open
Published: October 17, 2025
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer.
Journal: ESMO open
Published: October 17, 2025
Improved survival and rising incidence: insights from the largest retrospective study on leptomeningeal metastases in patients with NSCLC: Editorial on: The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 07, 2025
Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer Registry.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 23, 2025
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50.
Journal: ESMO open
Published: August 26, 2025
Last Updated: 09/26/2026